PRESS RELEASES

Vantage mHealthcare Board of Directors Votes to Develop Marijuana Detection Capability for its Sensor

April 21, 2015

New York, NY – Vantage mHealthcare Inc., (OTCQB: VNTH) ("Vantage") or (the "Company") today announced that its Board of Directors voted to develop a marijuana detection capability for its sensor. The Board determined it would be in the Company’s and shareholders best interest to bring the background and knowledge of our president and board member, Joseph C.

Vantage mHealthcare Improves Design and Technology of its Sensor | Expects to Deploy First 100 Sensors to Hospitals and Research Facilities in the United States and New Zealand

March 9, 2015

New York, NY –  Vantage mHealthcare Inc., (OTCQB: VNTH) ("Vantage") or (the "Company") today announced that Vantage’s manufacturer expects to deliver 100 Health Sensors over the next month to hospitals and research facilities in the United States and New Zealand, advancing to the next phase of its research and development process, in order to prepare for human clinical trials.

Vantage Health Announces Corporate Name Change to Vantage mHealthcare, Inc. | Company Amends State of Incorporation to Delaware

January 9, 2015

New York, NY – Vantage mHealthcare, Inc. (OTCQB: VNTH) (“Vantage Health” or the “Company”) today announced that the corporate name has officially changed to Vantage mHealthcare, Inc. to better align the strategic direction of the Company within the growing and innovative mobile healthcare technology sector.

Vantage Health Forms Strategic Partnership with Theranostics Laboratory

October 29, 2014

Redwood City, CA – Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health") or (the "Company") today announced that the Company has entered into a strategic partnership with Theranostics Laboratory, a translational research company, with offices in the USA and New Zealand. Theranostics laboratory was founded at the Cleveland Clinic in 2010 and works on subcontracted research, in collaboration with the Auckland Bioengineering Institute (ABI), in New Zealand, and with NASA (via NASA Grant NCC 9-58).

Vantage Health Announces Appointment of Joseph C. Peters, former White House Drug Policy Office’s Acting Deputy Director for State and Local Affairs under Presidents Clinton and Bush, to Its Board of Directors

September 24, 2014

Redwood City, CA  – Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health") or (the "Company") today announced the appointment of Joseph C. Peters to its Board of Directors, effective immediately. Mr. Peters will also serve as President of the company.  Among other things, he will be involved in exploring possible applications of the company’s technology to narcotics detection.  Mr. Peters will replace departing board member Will Rees.

Vantage Health Names Dr. Steven R. Steinhubl, Director of Digital Medicine at Scripps Translational Science Institute, New Chairman of the Board

September 23, 2014

Redwood City, CA  – Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health") or (the "Company") today announced the appointment of Steven R. Steinhubl, M.D. as chairman of the board.  Dr. Steinhubl replaces interim chairman, Dr. Kevin Buckman who will remain with the company in an advisory capacity.

Tony van Bijleveld, General Manager for Patheon/DPX, and former General Manager Europe for Alliance Boots Walgreens, Appointed to the Vantage Health Board of Directors

September 22, 2014

Redwood City, CA – Vantage Health Inc., (OTCQB: VNTH)  ("Vantage Health") or (the "Company") today announced the appointment of Tony van Bijleveld as an independent member of the Board of Directors of Vantage Health, Inc.

Pages